Medincell SA (MEDCL) - Total Liabilities

Latest as of March 2026: €104.99 Million EUR ≈ $122.74 Million USD

Based on the latest financial reports, Medincell SA (MEDCL) has total liabilities worth €104.99 Million EUR (≈ $122.74 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of Medincell SA to see how much of total assets are deployed in long-term investments.

Medincell SA - Total Liabilities Trend (2016–2026)

This chart illustrates how Medincell SA's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Medincell SA balance sheet assets.

Medincell SA Competitors by Total Liabilities

The table below lists competitors of Medincell SA ranked by their total liabilities.

Company	Country	Total Liabilities
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. SHE:301096	China	CN¥1.30 Billion
Changzhou Youon Pubilic Bicycle System Co Ltd SHG:603776	China	CN¥728.28 Million
Shenzhen Centralcon Investment Holding Co Ltd SHE:000042	China	CN¥30.05 Billion
Orient International Enterprise Ltd SHG:600278	China	CN¥11.22 Billion
Xiamen Guang Pu Electronics Co Ltd SHE:300632	China	CN¥1.01 Billion
Pexip Holding ASA OL:PEXIP	Norway	Nkr508.69 Million
Dogus Otomotiv Servis ve Ticaret AS IS:DOAS	Turkey	TL58.84 Billion
AXISCADES Technologies Limited NSE:AXISCADES	India	Rs5.20 Billion

Liability Composition Analysis (2016–2026)

This chart breaks down Medincell SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Medincell SA's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.67	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	34.27	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.97	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medincell SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medincell SA (2016–2026)

The table below shows the annual total liabilities of Medincell SA from 2016 to 2026.

Year	Total Liabilities	Change
2026-03-31	€104.99 Million ≈ $122.74 Million	-1.71%
2025-03-31	€106.82 Million ≈ $124.88 Million	+37.35%
2024-03-31	€77.77 Million ≈ $90.92 Million	+8.57%
2023-03-31	€71.63 Million ≈ $83.75 Million	+24.20%
2022-03-31	€57.67 Million ≈ $67.43 Million	+5.46%
2021-03-31	€54.69 Million ≈ $63.94 Million	+26.41%
2020-03-31	€43.27 Million ≈ $50.58 Million	+36.31%
2019-03-31	€31.74 Million ≈ $37.11 Million	-14.45%
2018-03-31	€37.10 Million ≈ $43.38 Million	+45.20%
2017-03-31	€25.55 Million ≈ $29.87 Million	+159.47%
2016-03-31	€9.85 Million ≈ $11.51 Million	--

About Medincell SA

PA:MEDCL France Biotechnology

Market Cap

$898.42 Million

€768.47 Million EUR

Market Cap Rank

#9958 Global

#155 in France

Share Price

€21.40

Change (1 day)

-1.74%

52-Week Range

€20.24 - €38.46

All Time High

€38.46